Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)

PHASE2CompletedINTERVENTIONAL
Enrollment

614

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

September 30, 2013

Conditions
Heart Failure
Interventions
DRUG

Placebo

48-hour infusion of placebo

DRUG

Omecamtiv mecarbil

48-hour infusion of omecamtiv mecarbil; dose strength will depend on cohort assignment.

Trial Locations (150)

1023

Research Site, Budapest

1122

Research Site, Budapest

1125

Research Site, Budapest

1134

Research Site, Budapest

1309

Research Site, Sofia

1431

Research Site, Sofia

1527

Research Site, Sofia

2010

Research Site, Darlinghurst

2700

Research Site, Blagoevgrad

2800

Research Site, Sandanski

2820

Research Site, Bonheiden

3121

Research Site, Richmond

3181

Research Site, Prahran

4002

Research Site, Plovdiv

4011

Research Site, Stavanger

4102

Research Site, Woolloongabba

4400

Research Site, Smolyan

4700

Research Site, Pazardzhik

5004

Research Site, Szolnok

5042

Research Site, Bedford Park

6100

Research Site, Kazanlak

7624

Research Site, Pécs

8800

Research Site, Roeselare

9000

Research Site, Ghent

9300

Research Site, Aalst

10467

Research Site, The Bronx

10567

Research Site, Cortlandt Manor

11528

Research Site, Athens

11576

Research Site, Roslyn

12462

Research Site, Haidari

14033

Research Site, Caen

16673

Research Site, Athens

17475

Research Site, Greifswald

19718

Research Site, Newark

20246

Research Site, Hamburg

20521

Research Site, Turku

21201

Research Site, Baltimore

25125

Research Site, Brescia

26500

Research Site, Pátrai

27100

Research Site, Pavia

27103

Research Site, Winston-Salem

27599

Research Site, Chapel Hill

27705

Research Site, Durham

28204

Research Site, Charlotte

29425

Research Site, Charleston

29605

Research Site, Greenville

30322

Research Site, Atlanta

31403

Research Site, Toulouse

32803

Research Site, Orlando

33100

Research Site, Udine

33133

Research Site, Miami

33308

Research Site, Fort Lauderdale

33462

Research Site, Atlantis

33756

Research Site, Clearwater

34295

Research Site, Montpellier

36608

Research Site, Mobile

37203

Research Site, Nashville

37388

Research Site, Tullahoma

38120

Research Site, Memphis

43210

Research Site, Columbus

44109

Research Site, Cleveland

44137

Research Site, Dortmund

45014

Research Site, Fairfield

45219

Research Site, Cincinnati

45220

Research Site, Cincinnati

45267

Research Site, Cincinnati

48201

Research Site, Detroit

48202

Research Site, Detroit

48374

Research Site, Novi

50009

Research Site, Kaunas

55417

Research Site, Minneapolis

59037

Research Site, Lille

60488

Research Site, Frankfurt

60590

Research Site, Frankfurt

60611

Research Site, Chicago

61231

Research Site, Bad Nauheim

61636

Research Site, Peoria

63110

Research Site, St Louis

63225

Research Site, Langen

66421

Research Site, Homburg

67091

Research Site, Strasbourg

68506

Research Site, Lincoln

70376

Research Site, Stuttgart

71110

Research Site, Heraklion

73120

Research Site, Oklahoma City

75010

Research Site, Paris

75651

Research Site, Paris

77030

Research Site, Houston

84107

Research Site, Murray

90301

Research Site, Inglewood

92037

Research Site, La Jolla

93053

Research Site, Regensburg

94121

Research Site, San Francisco

97080

Research Site, Würzburg

97239

Research Site, Portland

109240

Research Site, Moscow

111539

Research Site, Moscow

115093

Research Site, Moscow

117292

Research Site, Moscow

119620

Research Site, Moscow

119991

Research Site, Moscow

127299

Research Site, Moscow

127473

Research Site, Moscow

195067

Research Site, Saint Petersburg

196247

Research Site, St.-Petrsburg

197341

Research Site, Saint Petersburg

198205

Research Site, Saint Petersburg

199106

Research Site, Saint Petersburg

06810

Research Site, Danbury

07103

Research Site, Newark

37232-8802

Research Site, Nashville

T2N 4Z6

Research Site, Calgary

T6G 2B7

Research Site, Edmonton

T6L 5X8

Research Site, Edmonton

B3H 3A7

Research Site, Halifax

K1Y 4W7

Research Site, Ottawa

M5B 1W8

Research Site, Toronto

M5G 1X5

Research Site, Toronto

H3G 1A4

Research Site, Montreal

G1V 4G5

Research Site, Québec

J1H 5N4

Research Site, Sherbrooke

625 00

Research Site, Brno

656 91

Research Site, Brno

128 08

Research Site, Prague

150 06

Research Site, Prague

401 13

Research Site, Ústí nad Labem

00029

Research Site, Helsinki

01307

Research Site, Dresden

06097

Research Site, Halle

09134

Research Site, Cagliari

08661

Research Site, Vilnius

2625 AD

Research Site, Delft

7416 SE

Research Site, Deventer

3584 CX

Research Site, Utrecht

0424

Research Site, Oslo

15-276

Research Site, Bialystok

80-952

Research Site, Gdansk

31-202

Research Site, Krakow

31-501

Research Site, Krakow

91-347

Research Site, Lodz

20-954

Research Site, Lublin

50-981

Research Site, Wroclaw

826 06

Research Site, Bratislava

851 07

Research Site, Bratislava

040 66

Research Site, Košice

949 01

Research Site, Nitra

BS2 8HW

Research Site, Bristol

HU16 5JQ

Research Site, Cottingham

G11 6NT

Research Site, Glasgow

HA1 3UJ

Research Site, Harrow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cytokinetics

INDUSTRY

NCT01300013 - Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF) | Biotech Hunter | Biotech Hunter